http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg#head http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg http://www.nanopub.org/nschema#hasAssertion http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg#assertion http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg http://www.nanopub.org/nschema#hasProvenance http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg#provenance http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg http://www.nanopub.org/nschema#hasPublicationInfo http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg#assertion http://rdf.disgenet.org/resource/gda/DGN52b7b55dcf784e3a924de359985865e1 http://semanticscience.org/resource/SIO_000628 http://identifiers.org/ncbigene/1302 http://rdf.disgenet.org/resource/gda/DGN52b7b55dcf784e3a924de359985865e1 http://semanticscience.org/resource/SIO_000628 http://linkedlifedata.com/resource/umls/id/C1140680 http://rdf.disgenet.org/resource/gda/DGN52b7b55dcf784e3a924de359985865e1 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://semanticscience.org/resource/SIO_001123 http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg#provenance http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg#assertion http://purl.org/dc/terms/description [In this study, we examined the respective roles of the ATR and Chk1 kinases in ovarian cancer cells using genetic and pharmacologic inhibitors in combination with cisplatin, topotecan, gemcitabine, and the PARP inhibitor veliparib (ABT-888), four agents with clinical activity in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine. http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg#assertion http://purl.org/ontology/wi/core#evidence http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg#assertion http://semanticscience.org/resource/SIO_000772 http://identifiers.org/pubmed/23548269 http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://rdf.disgenet.org/v5.0.0/void/BEFREE http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg#assertion http://www.w3.org/ns/prov#wasGeneratedBy http://purl.obolibrary.org/obo/ECO_0000203 http://rdf.disgenet.org/v5.0.0/void/BEFREE http://purl.org/pav/importedOn 2017-02-19 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://purl.obolibrary.org/obo/ECO_0000212 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#comment Gene-disease associations inferred from text-mining the literature. http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#label DisGeNET evidence - LITERATURE http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg http://purl.org/dc/terms/created 2017-10-17T13:11:40+02:00 http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg http://purl.org/dc/terms/rights http://opendatacommons.org/licenses/odbl/1.0/ http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg http://purl.org/dc/terms/rightsHolder http://rdf.disgenet.org/v5.0.0/void/IBIGroup http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg http://purl.org/dc/terms/subject http://semanticscience.org/resource/SIO_000983 http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg http://purl.org/net/provenance/ns#usedData http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg http://purl.org/pav/authoredBy http://orcid.org/0000-0001-5999-6269 http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg http://purl.org/pav/authoredBy http://orcid.org/0000-0002-7534-7661 http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg http://purl.org/pav/authoredBy http://orcid.org/0000-0002-9383-528X http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg http://purl.org/pav/authoredBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg http://purl.org/pav/authoredBy http://orcid.org/0000-0003-1244-7654 http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg http://purl.org/pav/createdBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP231050.RAxoTIVk8J23JHA3HmYwfuBserbp3R9RU5bxYsG9EsELg http://purl.org/pav/version v5.0.0.0 http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://purl.org/pav/version v5.0.0